Simplex Trading, LLC Eagle Pharmaceuticals, Inc. Transaction History

Simplex Trading, LLC

$2.81 Billion
Q3 2024

A detailed history of Simplex Trading, LLC transactions in Eagle Pharmaceuticals, Inc. stock. As of the latest transaction made, Simplex Trading, LLC holds 8,355 shares of EGRX stock, worth $4,845. This represents 0.0% of its overall portfolio holdings.

Number of Shares

8,355

Holding current value

$4,845

% of portfolio

0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	BUY	$3.71 - $6.07 $30,997 - $50,714	8,355 New	8,355 $30,000
Q4 2023 Feb 02, 2024	BUY	$4.63 - $15.21 $132,968 - $436,815	28,719 Added 12486.52%	28,949 $151,000
Q3 2023 Nov 01, 2023	BUY	$15.21 - $22.88 $3,498 - $5,262	230 New	230 $3,000
Q4 2020 Feb 02, 2021	SELL	$41.72 - $51.34 $58,825 - $72,389	-1,410 Closed	0 $0
Q3 2020 Oct 14, 2020	SELL	$37.02 - $51.28 $85,849 - $118,918	-2,319 Reduced 62.19%	1,410 $59,000
Q2 2020 Jul 13, 2020	SELL	$43.24 - $55.02 $801,150 - $1.02 Million	-18,528 Reduced 83.25%	3,729 $178,000
Q1 2020 Apr 29, 2020	BUY	$34.37 - $60.07 $764,973 - $1.34 Million	22,257 New	22,257 $1.02 Million
Q1 2019 Apr 18, 2019	SELL	$38.66 - $51.82 $902,363 - $1.21 Million	-23,341 Closed	0 $0
Q4 2018 Jan 16, 2019	BUY	$36.72 - $67.73 $769,871 - $1.42 Million	20,966 Added 882.78%	23,341 $940,000
Q3 2018 Oct 23, 2018	BUY	$66.65 - $83.86 $158,293 - $199,167	2,375 New	2,375 $164,000
Q2 2018 Jul 30, 2018	SELL	$51.25 - $76.62 $120,335 - $179,903	-2,348 Closed	0 $0
Q1 2018 Apr 26, 2018	SELL	$52.16 - $66.86 $181,621 - $232,806	-3,482 Reduced 59.73%	2,348 $123,000
Q4 2017 Jan 10, 2018	BUY	$49.6 - $60.87 $156,190 - $191,679	3,149 Added 117.46%	5,830 $311,000
Q3 2017 Oct 25, 2017	BUY	$46.62 - $60.36 $124,988 - $161,825	2,681	2,681 $159,000

Others Institutions Holding EGRX

# of Institutions

Shares Held

8.6M

Call Options Held

Put Options Held

100

View Full List

About EAGLE PHARMACEUTICALS, INC.

Ticker EGRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 13,015,900
Market Cap $7.55M
Description
Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...

More about EGRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.

Account